CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Standard Automatic Perimetry Humphrey Field Analyzer +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03804684
NCT03804684N/ACompleted
CompareCT.gov

How Does the visuALL Field Analyzer (vFA) Compare to Standard Automatic Perimetry (SAP) in Patients With Mild and Moderate Chronic Open Angle Glaucoma (COAG) and Subjects Without Eye Problems?

Wills Eye·interventional·Posted Jan 15, 2019·Updated Jun 29, 2022

In Brief

A clinical study evaluating Standard Automatic Perimetry Humphrey Field Analyzer and visuALL Field Analyzer for Glaucoma, Open-Angle. Completed, enrolled 72 participants across 1 site.

Detailed Summary

To determine age-adjusted reference values of the visuALL Field Analyzer (vFA) retinal sensitivity and to assess the repeatability of the measured values and compare them with those measured by a Standard Automatic Perimetry (SAP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open-Angle
CountriesUnited States
CollaboratorsOlleyes, Inc.

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 15, 2019
Enrollment StartJan 8, 2019
Primary CompletionOct 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.5 years ago

Interventions

Standard Automatic Perimetry Humphrey Field Analyzerother

Standard Automatic Perimetry (SAP) Humphrey Field Analyzer (HFA) 24-2, Swedish Interactive Threshold Algorithm (SITA) Standard Strategy measures peripheral and central vision in an ophthalmic setting.

visuALL Field Analyzerother

visuALL Field Analyzer a new portable hardware and software virtual reality system measures peripheral and central vision to improve early detection of glaucoma damage in a non ophthalmic setting.